XML 15 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues:        
Premiums $ 18,984 $ 17,182 $ 56,927 $ 51,749
Net investment income 246 204 832 550
Total revenues 73,794 67,056 215,507 199,152
Operating costs:        
Cost of products sold $ 45,011 $ 40,940 $ 129,425 $ 121,529
Cost, Product and Service [Extensible List] Products Products Products Products
Benefit costs $ 16,081 $ 14,396 $ 47,686 $ 40,534
Goodwill impairment 431 0 431 0
Operating expenses 9,210 8,471 27,001 25,702
Total operating costs 70,733 63,807 204,543 187,765
Operating income 3,061 3,249 10,964 11,387
Interest expense 602 731 1,895 2,229
Loss on early extinguishment of debt 363 766 363 766
Other income (49) (54) (144) (153)
Income before income tax provision 2,145 1,806 8,850 8,545
Income tax provision 558 587 2,248 2,328
Net income 1,587 1,219 6,602 6,217
Net (income) loss attributable to noncontrolling interests 11 5 2 (11)
Net income attributable to CVS Health $ 1,598 $ 1,224 $ 6,604 $ 6,206
Net income per share attributable to CVS Health:        
Net income per share attributable to CVS Health, basic (in dollars per share) $ 1.21 $ 0.93 $ 5.01 $ 4.74
Net income per share attributable to CVS Health, diluted (in dollars per share) $ 1.20 $ 0.93 $ 4.98 $ 4.72
Weighted average shares outstanding:        
Weighted average basic shares outstanding (in shares) 1,321 1,310 1,318 1,308
Weighted average diluted shares outstanding (in shares) 1,329 1,315 1,326 1,314
Dividends declared per share (in dollars per share) $ 0.50 $ 0.50 $ 1.50 $ 1.50
Products        
Revenues:        
Revenues $ 51,853 $ 47,738 $ 149,765 $ 141,096
Services        
Revenues:        
Revenues $ 2,711 $ 1,932 $ 7,983 $ 5,757